Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,065 public trials 1,848 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLC

NCT07449858

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Guangdong Second Provincial General Hospital Guangzhou, Guangdong, China
  • The First Hospital of China Medical University Shenyang, Liaoning, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
  • The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details
Active, not recruiting

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

NCT04819100

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • UCLA Hematology/Oncology - Santa Monica Los Angeles, California, United States
  • Stockton Hematology Oncology Group Stockton, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States
  • GenesisCare Aventura, Florida, United States
View all 211 locations
View Trial Details
Active, not recruiting

Palliative Thoracic ImmunoRT

NCT03705806

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University Health Network, Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Active, not recruiting

Study of Oral MRT-2359 in Selected Cancer Patients

NCT05546268

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +38 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Kansas Cancer Center Lawrence, Kansas, United States
View all 17 locations
View Trial Details
Active, not recruiting

First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

NCT05361395

Conditions
Bites and Stings, Chemically-Induced Disorders, Extensive Stage Small Cell Lung Cancer, +9 more
Locations
  • University of Southern California, Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Christiana Care Health Services Newark, Delaware, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View all 44 locations
View Trial Details
Active, not recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

NCT05907304

Conditions
Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +34 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Florida Cancer Specialists - St. Petersburg St. Petersburg, Florida, United States
View all 29 locations
View Trial Details
Active, not recruiting

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

NCT04336241

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +25 more
Locations
  • Hospital Universitario d'Hebron Barcelona, Spain
  • Hospital Universitario HM Sanchinarro Madrid, Spain
  • Hospital Clinico de Valencia Valencia, Spain
  • The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Merseyside, United Kingdom
View Trial Details
Active, not recruiting

Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)

NCT04602533

Conditions
Lung Diseases, Lung Neoplasms, Neoplasms, +5 more
Locations
  • Klinikverbund Allgäu gGmbH Immenstadt im Allgäu, Bavaria, Germany
  • Asklepios Fachkliniken Muenchen Gauting München Gauting, Bavaria, Germany
  • Klinikum Ernst von Bergmann Potsdam, Brandenburg, Germany
  • Universitätsklinikum Gießen Marburg Giessen, Hesse, Germany
View all 15 locations
View Trial Details

Related conditions